CIK 0000897448 · Accelerated filer
AMARIN CORP PLCUK
Sign in to watch- Ticker
- AMRN
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- United Kingdom
- Entity type
- operating
- Phone
- 353 1 6699 020
- Business address
- SPACES SOUTH DOCKLANDS, BLOCK C, 77 SIR JOHN ROGERSON'S QUAY, DUBLIN 2, Ireland
- Former names
- AMARIN CORP PLC\UK, AMARIN PHARMACEUTICALS PLC, ETHICAL HOLDINGS PLC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2019-05-20 | Zakrzewski Joseph S Director | Grant or award · Restricted Stock Units | +7,428 | 7,428 | ||
| 2019-05-20 | VAN HEEK G JAN Director | Grant or award · Stock Option (Right to Buy) | +9,658 | 9,658 | ||
| 2019-05-20 | VAN HEEK G JAN Director | Grant or award · Restricted Stock Units | +7,428 | 7,428 | ||
| 2019-05-20 | Peterson Kristine Director | Grant or award · Stock Option (Right to Buy) | +9,658 | 9,658 | ||
| 2019-05-20 | Peterson Kristine Director | Grant or award · Restricted Stock Units | +7,428 | 7,428 | ||
| 2019-05-20 | O'Sullivan Patrick J Director | Grant or award · Stock Option (Right to Buy) | +9,658 | 9,658 | ||
| 2019-05-20 | O'Sullivan Patrick J Director | Grant or award · Restricted Stock Units | +7,428 | 7,428 | ||
| 2019-05-20 | Ekman Lars Director | Grant or award · Stock Option (Right to Buy) | +10,431 | 10,431 | ||
| 2019-05-20 | Ekman Lars Director | Grant or award · Restricted Stock Units | +8,023 | 8,023 | ||
| 2019-05-17 | STACK DAVID M Director | Option exercise | +13,174 | $3.21 | $42K | 13,174 |
| 2019-05-17 | STACK DAVID M Director | Sale | −13,174 | $18.00 | $237K | 0 |
| 2019-05-17 | STACK DAVID M Director | Option exercise · Stock Option (Right to Buy) | −13,174 | 33,799 | ||
| 2019-05-01 | Berg Aaron CHIEF COMMERCIAL OFFICER | Option exercise | +26,000 | 62,351 | ||
| 2019-05-01 | Berg Aaron CHIEF COMMERCIAL OFFICER | Shares withheld for taxes | −12,805 | $18.70 | $239K | 49,546 |
| 2019-05-01 | Berg Aaron CHIEF COMMERCIAL OFFICER | Option exercise · Restricted Stock Units | −26,000 | 52,000 | ||
| 2019-04-30 | Ketchum Steven B Chief Scientific Officer | Option exercise | +2,604 | $1.40 | $4K | 357,096 |
| 2019-04-30 | Ketchum Steven B Chief Scientific Officer | Option exercise | +4,166 | $2.50 | $10K | 361,262 |
| 2019-04-30 | Ketchum Steven B Chief Scientific Officer | Option exercise | +2,771 | $2.95 | $8K | 364,033 |
| 2019-04-30 | Ketchum Steven B Chief Scientific Officer | Sale | −9,541 | $18.67 | $178K | 354,492 |
| 2019-04-30 | Ketchum Steven B Chief Scientific Officer | Option exercise · Stock Option (Right to Buy) | −2,604 | 23,436 |
Page 65 of 67 · 1,339 trades